We observed that the cells double-positive for NRP1 and FXYD3 (ancestor-like CSC enriched) were increased by paclitaxel treatment and they were significantly diminished by combined treatment with ouabain in cancer tissues (Figure 7F). This evidence concerns the gene NRP1 and cancer.